Elasmogen
PrivateLast Round
Series A
May 18, 2022
Total Funding Raised
$17.82M
Company Overview
Elasmogen is a biopharmaceutical company that develops therapeutic biologics, specifically soloMERs, for the treatment of cancer and inflammatory, autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elasmogen Comparables
Compare Elasmogen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ossianix | 83% | |
| Cortalix B.V. | 82% | |
| Singh Biotechnology | 78% | |
Elasmogen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 18, 2022 | ||||
| Grant | Jul 8, 2020 | ||||
| Seed | Jan 10, 2020 | ||||
| Grant | Mar 16, 2017 | ||||
| Seed | Mar 16, 2017 | ||||
Seed | Feb 1, 2016 |
Key People
Founding team and executive leadership
Elasmogen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BGF | Series A |
| Innovate UK | Grant |
| Deepbridge Capital | Seed, Grant |
| Scottish National Investment Bank | Series A |
| Biotechnology and Biological Sciences Research Council | Grant |
| Scottish Investment Bank (Scottish Enterprise) | Series A, Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Monthly visitors grew 36% MoM.
- Jul 3, 2025
Monthly visitors grew 157% MoM, reaching 457.
Elasmogen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elasmogen's valuation, stock price, and market status.